Farma Dewolf SRL
Farma Dewolf reported total assets of 75,439 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of Farma Dewolf shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets +65 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farma Dewolf's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 07 Aug 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Farma Dewolf's financial analysis
- Solvency84.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farma Dewolf
Farma Dewolf's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0568.877.779
- VAT number
- BE0568877779
- Peppol
- Registered · 0208:0568877779 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jan 2015
- Registered office
- 3020 Herent
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farma Dewolf (SRL) has been based in Herent since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 23,602 € and equity of 63,874 €; its revenue is not published. Its solvency stands at 84.7%, above the median of its sector (44.2%).
Companies similar to Farma Dewolf
Companies in the same business, of comparable size and area, outside its group.
- Gonnissen - Hollanders Retail sale of pharmaceutical products Antwerp · balance sheet 75,759 €
- DD Pharma Retail sale of pharmaceutical products Leuven · balance sheet 75,776 €
- Pharmacie Stalingrad Retail sale of pharmaceutical products Brussels · balance sheet 75,864 €
- ESPharma Retail sale of pharmaceutical products Anderlecht · balance sheet 74,825 €
- Arucarea Retail sale of pharmaceutical products Oud-Turnhout · balance sheet 73,983 €
- Sagenex Retail sale of pharmaceutical products Namur · balance sheet 73,820 €
- Sirrah Retail sale of pharmaceutical products Tournai · balance sheet 84,897 €
- Arkophar Retail sale of pharmaceutical products Zutendaal · balance sheet 73,718 €
Frequently asked questions about Farma Dewolf
What is the revenue of Farma Dewolf?
Farma Dewolf files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farma Dewolf?
In Belgium, the VAT number is the company number prefixed with BE: BE0568877779 for Farma Dewolf, if the company is VAT-registered. Its company number (CBE) is 0568.877.779.
Where is the registered office of Farma Dewolf?
According to the CBE register, the registered office of Farma Dewolf is in 3020 Herent.
What is the equity of Farma Dewolf?
At the close of the 2025 financial year, the equity of Farma Dewolf amounts to 63,874 €, a solvency of 84.7% of total assets.
Who manages Farma Dewolf?
The register lists 1 active mandates at Farma Dewolf. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farma Dewolf
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →